Menu
Landing Page Devicesv2

Accessibility

Not an actual patient.

The Site is brought to you by Sinclair Pharma Ltd (Sinclair). Our registered office is 30-32 Whitfield Street, Whitfield Court, London, W1T 2RQ with company registration number 03816616.

Sinclair recognises the importance of providing a website that is accessible to all user groups including people with disabilities such as blindness and low vision, deafness and hearing loss, learning disabilities, cognitive limitations, limited movement, speech disabilities, photosensitivity and combinations of these.

Sinclair has designed the Site with accessibility in mind, following the guidelines laid down by the W3C Web Accessibility Initiative (WAI).

Web Content Accessibility Guidelines (WCAG) 2.0 covers a wide range of recommendations for making web content more accessible to a wider range of people with disabilities and will also often make web content more usable to users in general.

The 12 accessibility guidelines are:

  • Provide text alternatives for non-text content.
  • Provide captions and alternatives for audio and video content.
  • Make content adaptable; and make it available to assistive technologies.
  • Use sufficient contrast to make things easy to see and hear.
  • Make all functionality keyboard accessible.
  • Give users enough time to read and use content.
  • Do not use content that causes seizures.
  • Help users navigate and find content.
  • Make text readable and understandable.
  • Make content appear and operate in predictable ways.
  • Help users avoid and correct mistakes.
  • Maximize compatibility with current and future technologies.
  • There are three levels of conformance to the accessibility guidelines: A (lowest), AA, and AAA (highest) and our aim is to conform to AA Level. However these are guidelines only and in some instances it is not practical to conform exactly to all checkpoints. If you have any queries about the accessibility of this website please contact enquiries@sinclairpharma.com

INDICATION: V-SERIES

Local laws vary regarding the delegation of Radiofrequency (RF), Fractional RF, IPL and long pulse 1064 nm Nd: YAG laser treatments to non-physicians and change over time. Please consult your local regulations.

Like all medical procedures, not all patients are suitable for V-SERIES treatments. The V-SERIES platforms (V10, V20 and V30) are multi-application devices, designed for aesthetic and dermatological procedures. Their clinical performance and safety are related to the handpiece and its technology. The V-SERIES handpieces include V-FC, V-FORM, V-ST, V-FR, V-VR, V-IPL and V-Nd: YAG.

The V-FORM and V-FC handpieces stimulate bi-polar RF energy and negative pressure (vacuum suction). The mechanical action of the vacuum stimulates the skin to increase blood microcirculation and lymphatic drainage while facilitating deeper penetration of RF heat to the dermis and hypodermis. The RF electrical current generates heat in the skin through resistance in the dermis and subcutaneous layers. This volumetric heating of the skin also increases blood microcirculation leading to enhanced natural lipolysis and therefore circumferential reduction.

The V-ST handpiece’s RF electrical current generates heat in the skin through resistance in the dermis and subcutaneous layers. Volumetric heating of the skin increases blood microcirculation, leading to collagen remodelling and skin tightening.

The V-VR Handpiece’s electrical current generates heat in the skin through resistance in the vaginal wall. Volumetric heating of the skin increases blood microcirculation leading to collagen remodelling, resulting vaginal laxity improvement.

The V-FR handpiece stimulatingly delves fractional bi-polar RF energy, contact cooling and negative pressure. RF heating increases the skin temperature to produce pin-point superficial ablation and dermal coagulation, leading to skin resurfacing.

The V-IPL handpiece emits a spectrum of light from a variety of “cut-off” filters (ranging from 415 nm up to 755 nm). The light absorbed by the skin’s target chromophores (light-sensitive molecules: water, melanin, hemoglobin, porphyrin) reacts to the light according to the principle of selective photo-thermolysis, leading to the temperature rise of the selected chromophore and its consequential destruction.

The V-Nd: YAG handpiece delivers light energy at 1064 nm and the skin’s target chromophores (light-sensitive molecules: water, melanin, hemoglobin) react to the light according to the principle of selective photo-thermolysis, leading to the temperature rise of the selected chromophore and its consequential destruction.

The treating practitioners and patients should discuss the V-SERIES procedure and review the risks and benefits of this procedure. Please review more detailed information regarding V-SERIES safety and indications.